Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-29 @ 6:53 AM
Study NCT ID:
NCT00594334
Status:
WITHDRAWN
Last Update Posted:
2022-07-19
First Post:
2008-01-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Actonel on Periodontal Health of Postmenopausal Women
Sponsor:
University Hospitals Cleveland Medical Center
Organization:
Study Overview
Official Title:
Effect of Actonel on Periodontal Health of Postmenopausal Women
Status:
WITHDRAWN
Status Verified Date:
2022-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Never started
Has Expanded Access:
True
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.
Detailed Description:
Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: